Transmedics Group Inc diskutieren
Transmedics Group Inc
WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Aktie / ? /
108,05 €
-0,41 %
TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $180.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Robert W. Baird from $200.00 to $150.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $200.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at JPMorgan Chase & Co. from $173.00 to $116.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $180.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at TD Cowen from $175.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Piper Sandler from $180.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $125.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Robert W. Baird from $150.00 to $120.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Piper Sandler from $110.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $105.00 price target on the stock, up previously from $90.00.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $125.00 price target on the stock, up previously from $105.00.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $125.00 to $130.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $145.00 price target on the stock, up previously from $125.00.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $130.00 to $150.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group (NASDAQ:TMDX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $155.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group (NASDAQ:TMDX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $145.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group (NASDAQ:TMDX) had its price target lowered by analysts at Piper Sandler from $145.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Needham & Company LLC from $148.00 to $166.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Neueste Beiträge
Roth_Capital in Gran Tierra Energy Inc. diskutieren